Response of the cellular immune system to cardiopulmonary bypass in vivo

Thoracic and Cardiovascular Surgeon

Volumn 45, Issue 5, 1997, Pages 217-223

  Misoph, M ^a   Babin Ebell, J ^a   Schwender, S ^a   Grossmann, R ^a   Keller, F ^a   Elert, O ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cardiopulmonary bypass; Flow cytometry; Immune response; Leukocyte subpopulations

Indexed keywords

CD45 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030726308     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013731     Document Type: Article

References (24)

1. Bonser RS, Dave J, Gademsetty M, et al. Complement activation before, during and after cardiopulmonary bypass. Eur J Cardiothorac Surg. 1990;4: 291-6.
2. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3 a and C5 a anaphylatoxins. N Engl J Med. 1981;304: 497-503.
3. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86: 845-57.
4. Boisclair MD, Lane DA, Philippou H, et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood. 1993;82 (11):3350-7.
5. Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost. 1985;11: 281-92.
6. Steinbrückner BE, Steigerwald U, Keller F, Neukam K, Elert O, Babin-Ebell J. Centrifugal and roller pumps - are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass? Heart Vessels. 1995;10: 46-53.
7. Tanaka K, Morimoto T, Yada I, Kusagawa M, Deguchi K. Physiologic role of enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery. Trans Am Soc Artif Intern Organs. 1987;33: 505-9.
8. Babin-Ebell J, Misoph M, Schwender S, et al. Biocompatibility of extracorporeal circulation. Thorac cardiovasc Surgeon. 1996;44 (Suppl):215-6.
9. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg. 1992;53: 833-8.
10. Haeffner-Cavaillon N, Roussellier N, Ponzio O. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1989;98: 1100-6.
11. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;106: 1008-16.
12. Borowiec J, Thelin S, Bagge L, Nillson L, Venge P, Hansson HE. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1992; 104: 642-7.
13. Schmid FX, Zhou X, Hake U, et al. Zell-vermittelter Immunstatus während und nach Operationen mit und ohne extrakorporaler Zirkulation. Z Herz-, Thorax-, Gefäßchir. 1996;10: 153-61.
14. Ide H, Kakiuchi T, Furuta N, et al. The effect of cardiopulmonary bypass on T cells and their subpopulations. Ann Thorac Surg. 1987;44: 277-82.
15. Markewitz A, Faist E, Lang S, Hültner L, Weinhold C, Reichart B. An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg. 1996;10: 61-7.
16. Pertillä J, Salo M, Pirttikangas C-O, Jalonen J, Vainio O. Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices. J Cardiothorac Anesth. 1994;8: 532-5.
17. Carpentier S, Murawsky M, Carpentier A. Cytotoxicity of cardioplegic solutions: evaluation by tissue culture. Circulation. 1981;64 (II):90-5.
18. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55: 552-9.
19. Royston D, Minty BD, Higenbottam TW, Wallwork J, Jones GJ. The effects of surgery with cardiopulmonary bypass on alveolar capillary barrier function in man. Ann Thorac Surg. 1985;40: 139-43.
20. Tajima K, Yamamoto F, Kawazoe K, et al. Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity. Ann Thorac Surg. 1993;55: 625-30.
21. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg. 1993;105: 15-24.
22. Markewitz A, Faist E, Lang S, Endres S, Hültner L, Reichart B. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg. 1993;55: 389-94.
23. Cebrián M, Yagüe E, Rincón M, López-Botet M, De Landázuri MO, Sánchez-Madrid E. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med. 1988;168: 1621-37.
24. Pulido R, Alvarez V, Mollinedo F, Sánchez-Madrid F. Biochemical and functional characterization of the leukocyte tyrosine phosphatase CD45 (CD45 RO, 180 kD) from human neutrophils. In vivo upregulation of CD45 RO plasma membrane expression on patients undergoing haemodialysis. Clin Exp Immunol. 1992;87 (2):329-35.